Tag: Sight Diagnostics

[Sight Diagnostics in PR Newswire] BD Collaborates with Sight Diagnostics to Introduce Parasight Malaria Detection Device in India

BD (Becton, Dickinson and Company) today announced a collaboration with Sight Diagnostics Ltd. (SightDX), to introduce the Parasight Malaria Detection Platform in India. Through this agreement BD will market the Parasight Platform in the Indian diagnostics market, adding to BD’s extensive infectious disease diagnostics portfolio. The collaboration will represent the first malaria diagnostics offering from BD. Read more on PR Newswire...

Read More

[Sight Diagnostics in Israel Rising] How Israeli Startup Sight Diagnostics is Mending Malaria

In 2015, there were 214 million recorded cases of malaria across the globe. Of those infected, approximately 483,000 victims died of the disease. Since infection is spread by mosquitoes, malaria is extremely easy to contract. To make matters worse, diagnosing the disease has proven difficult, and many cases have gone misdiagnosed because of the complexity of the procedure. For decades, the medical world has been desperately attempting to generate a vaccine for this deadly disease, but all efforts have yielded negative results. Read more on Israel...

Read More

[Sight Diagnostics in Geektime] Meet the Israeli startup that could stomp out malaria in Africa and India

For generations, malaria has taken a heavy toll on third world populations. It still ravages certain parts of the world. Among nearly 200 million cases last year, 438,000 people died of the disease in 2015 according to the World Health Organization; 90% of those were deaths in Africa. Yet there has been little change in diagnostics for decades. Analysis can sometimes take weeks and be inaccurate. But one Israeli startup is betting that it has broken new ground in battling the pervasive disease. Read more about Sight Diagnostics in...

Read More

[Sight Diagnostics featured in Forbes] Why Computers Will Eradicate Blood Borne Diseases

OurCrowd’s portfolio company SightDX was featured on Forbes, a leading business and finance magazine. The company is pioneering an innovative computer vision platform for cheaper, faster, and fully-automated blood diagnostics whose first application is the 300 million annual tests for Malaria worldwide. Israeli tech startup, SightDX uses computer vision to scan blood samples in search for diseases of the blood and it does so better, faster, and cheaper than humans can. The startup was founded by a multi-disciplinary team of biologists, engineers, and software programmers that merged their talents in disease detection and vision analysis to create a versatile platform capable of multi disease detection. “Creating a dynamic computer vision platform for blood diagnostics required us to merge expertise from numerous scientific and engineering disciplines. Our successful trials and commercialization of the malaria device demonstrates the proof of principle for the technology and paves the way for additional vision-based diagnostic applications on our platform.” — Yossi Pollak, CEO of SightDX SightDX raised $1,460,000 from OurCrowd investors in January 2014. Read more on...

Read More

Latest from Twitter